Alerts will be sent to your verified email
Verify Email
SHAMROIN
|
Shamrock Indl. Co
|
Saroja Pharma Ind
|
Chemo Pharma Labs
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-8.9 % | 33.33 % | -4.51 % |
|
5yr Avg Net Profit Margin
|
0.0 | 2.08 % | 0.0 |
|
Price to Book
|
11.85 | 0.0 | 1.45 |
|
P/E
|
0.0 | 18.67 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
0.0 | 80.28 Days | 0.0 |
|
5yr Average Interest Coverage Ratio
|
0.0 | 2.76 | 794.39 |
|
5yr Avg ROCE
|
-8.89 % | 37.65 % | -3.17 % |
|
5yr Avg Operating Profit Margin
|
0.0 | 4.76 % | 0.0 |
|
5 yr average Debt to Equity
|
0.0 | 1.78 | 0.01 |
|
5yr CAGR Net Profit
|
-28.89 % | 3.81 % | n/a |
|
5yr Average Return on Assets
|
-8.72 % | 6.13 % | -4.13 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
42.98 % | 73.02 % | 27.89 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Shamrock Indl. Co
|
Saroja Pharma Ind
|
Chemo Pharma Labs
|
|---|